Gilberto Pena Ledon, NP, RN

Gilberto Pena Ledon practices at UCSD Hillcrest Medical Center in San Diego, California.

Gilberto Pena Ledon's NPI, 1447598354, was assigned on January 28, 2013. Gilberto Pena Ledon holds California license NP22396.

Gilberto Pena Ledon's primary practice is UCSD Hillcrest Medical Center, at 200 W Arbor Dr, San Diego, CA 92103 in San Diego County. The practice phone is (619) 543-6222.

Gilberto Pena Ledon's primary practice is UCSD Hillcrest Medical Center in San Diego, California. Gilberto Pena Ledon is also affiliated with Hillcrest Medical Center. The medical group on file is UC San Diego Health.

Dmand AI tracks the electronic health record (EHR) system at each site where Gilberto Pena Ledon practices. Vendor and product names are available with a free account.

Nurse practitioner is Gilberto Pena Ledon's primary specialty in the NPI Registry, under taxonomy code 363L00000X. Gilberto Pena Ledon is licensed in California.

Dmand AI lists acute sinusitis, asthma, chronic nasal allergies, chronic obstructive pulmonary disease (COPD), chronic respiratory failure, chronic sinusitis, hypersomnia and pneumonia among the conditions Gilberto Pena Ledon treats.

CMS data shows 518 Medicare services from Gilberto Pena Ledon across 2 procedure codes in 2024, all of them office visits, for 328 Medicare patients. Medicare paid $54,170 for them.

CMS counts 328 Medicare patients who saw Gilberto Pena Ledon in 2024. The largest group is 65 to 74, with 130 patients. 75% of them have high cholesterol, and 74% have high blood pressure. 34% are also on Medicaid. Their average risk score is 2.09, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Gilberto Pena Ledon's median patient age at 66, with 60% women.

In 2024, Gilberto Pena Ledon wrote 1,798 Medicare Part D claims for 300 patients. 44% of them were for generic drugs. CMS names the drug for 1,662 of them, across 28 drugs with 11 or more claims each, at $431,049 in total drug cost.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 91 out of 100 for Gilberto Pena Ledon for performance year 2024, reported as part of a group. Gilberto Pena Ledon accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Gilberto Pena Ledon as offering telehealth.

CMS Open Payments shows 3 general payments to Gilberto Pena Ledon from 2 drug and device companies from 2024 to 2025. Food and beverage make up the largest share, 100% of the total. GlaxoSmithKline, LLC. paid the most, $42.